Contact
Please use this form to send email to PR contact of this press release:
BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone
TO:
Please use this form to send email to PR contact of this press release:
BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone
TO: